ES2141117T3 - Agentes farmaceuticos con sabor enmascarado. - Google Patents
Agentes farmaceuticos con sabor enmascarado.Info
- Publication number
- ES2141117T3 ES2141117T3 ES93100079T ES93100079T ES2141117T3 ES 2141117 T3 ES2141117 T3 ES 2141117T3 ES 93100079 T ES93100079 T ES 93100079T ES 93100079 T ES93100079 T ES 93100079T ES 2141117 T3 ES2141117 T3 ES 2141117T3
- Authority
- ES
- Spain
- Prior art keywords
- pharmaceutical agents
- taste
- masked taste
- masked
- medicines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
LA INVENCION CONCIERNE A UN PREPARADO FARMACEUTICO, CON SABOR ENMASCARADO, PARA USO POR VIA ORAL, A SU OBTENCION Y SU UTILIZACION COMO MEDICAMENTO. CON AYUDA DE LAS NUEVAS PREPARACIONES MEDICINALES DE LA INVENCION SE HACE POSIBLE QUE SUSTANCIAS ACTIVAS FARMACEUTICAS, CON PROPIEDADES ORGANOLEPTICAS MUY DESAGRADABLES, COMO P. EJ. EL MUY MAL SABOR, TAMBIEN PUEDAN SER ADMINISTRADAS EN FORMA LIQUIDA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4200821A DE4200821A1 (de) | 1992-01-15 | 1992-01-15 | Geschmacksmaskierte pharmazeutische mittel |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2141117T3 true ES2141117T3 (es) | 2000-03-16 |
Family
ID=6449525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES93100079T Expired - Lifetime ES2141117T3 (es) | 1992-01-15 | 1993-01-05 | Agentes farmaceuticos con sabor enmascarado. |
Country Status (24)
Country | Link |
---|---|
US (2) | US5695784A (es) |
EP (1) | EP0551820B1 (es) |
JP (1) | JP3734279B2 (es) |
KR (1) | KR100288523B1 (es) |
CN (1) | CN1052399C (es) |
AT (1) | ATE186212T1 (es) |
AU (1) | AU670763B2 (es) |
CA (1) | CA2087146C (es) |
CZ (1) | CZ283787B6 (es) |
DE (2) | DE4200821A1 (es) |
DK (1) | DK0551820T3 (es) |
ES (1) | ES2141117T3 (es) |
GR (1) | GR3032382T3 (es) |
HK (1) | HK1005987A1 (es) |
HU (2) | HU219592B (es) |
IL (1) | IL104362A (es) |
MX (1) | MX9207630A (es) |
MY (1) | MY111177A (es) |
NZ (1) | NZ245658A (es) |
PL (1) | PL175569B1 (es) |
RU (1) | RU2110255C1 (es) |
SK (1) | SK280999B6 (es) |
TW (1) | TW366286B (es) |
ZA (1) | ZA93234B (es) |
Families Citing this family (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4200821A1 (de) * | 1992-01-15 | 1993-07-22 | Bayer Ag | Geschmacksmaskierte pharmazeutische mittel |
DE29502547U1 (de) * | 1995-02-16 | 1995-03-30 | Röhm GmbH, 64293 Darmstadt | Thermoplastisches Überzugs- und Bindemittel für Arzneiformen |
US5840332A (en) * | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
AUPN969796A0 (en) * | 1996-05-07 | 1996-05-30 | F.H. Faulding & Co. Limited | Taste masked liquid suspensions |
US5766622A (en) * | 1996-08-14 | 1998-06-16 | The Procter & Gamble Company | Inhibiting undesirable taste in oral compositions |
DE19706978A1 (de) * | 1997-02-21 | 1998-08-27 | Ulrich Dr Posanski | Kombinationspräparat für oral applizierbare Antibiotika |
FI111796B (fi) * | 1997-05-28 | 2003-09-30 | Finnfeeds Finland Oy | Kiinteä betaiinituote, menetelmä sen valmistamiseksi, ja sen käyttö |
DE19809719A1 (de) * | 1998-03-06 | 1999-09-09 | Roehm Gmbh | Wäßrige Dispersion geeignet zur Herstellung von Überzugs- und Bindemitteln für feste orale Arzneiformen |
US5976507A (en) * | 1998-06-04 | 1999-11-02 | Colgate Palmolive Company | Dentrifice composition containing encapsulated reactive ingredients |
US6727283B2 (en) * | 1998-10-13 | 2004-04-27 | Pfizer Inc. | Sertraline oral concentrate |
US6432448B1 (en) | 1999-02-08 | 2002-08-13 | Fmc Corporation | Edible coating composition |
US6723342B1 (en) | 1999-02-08 | 2004-04-20 | Fmc Corporation | Edible coating composition |
US6270807B1 (en) * | 1999-03-02 | 2001-08-07 | L. Perrigo Company | Taste-masked pharmaceutical composition |
DE19913692A1 (de) | 1999-03-25 | 2000-09-28 | Basf Ag | Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen |
GB9911546D0 (en) * | 1999-05-19 | 1999-07-21 | Core Technologies Limited | Release of poorly soluble agents |
DE19930557B4 (de) * | 1999-07-02 | 2005-12-08 | Bayer Healthcare Ag | Verfahren zur Herstellung von Hydraten von Ciprofloxacin und von Ciprofloxacin-Anhydrat enthaltenden pharmazeutischen Zusammensetzungen |
JP2003504335A (ja) | 1999-07-09 | 2003-02-04 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 味を覆い隠した液状の薬学的調剤 |
FR2798289B1 (fr) * | 1999-09-15 | 2004-12-31 | Cll Pharma | Formes galeniques a delitement rapide en bouche et leur procede de preparation |
US6500462B1 (en) | 1999-10-29 | 2002-12-31 | Fmc Corporation | Edible MCC/PGA coating composition |
ATE250415T1 (de) * | 1999-12-22 | 2003-10-15 | Hoffmann La Roche | Arzneizusammensetzung enthaltend ascorbinsäure und pektin |
DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
WO2001091730A1 (en) | 2000-05-31 | 2001-12-06 | Drugtech Corporation | Mineral supplement |
DE10031043A1 (de) | 2000-06-26 | 2002-02-14 | Bayer Ag | Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung |
AU2002225763A1 (en) | 2000-11-28 | 2002-06-11 | Fmc Corporation | Edible pga(propylene glycol alginate) coating composition |
US20020122824A1 (en) * | 2001-01-24 | 2002-09-05 | Francisco Cabrera | Solid phase dispersion of quinolone-or naphthyridonecarboxylic acids |
BR0207932A (pt) | 2001-03-05 | 2004-03-02 | Ortho Mcneil Pharm Inc | Composições farmacêuticas de sabor mascarado |
JP4705747B2 (ja) * | 2001-05-30 | 2011-06-22 | ユーロセルティック ソシエテ アノニム | 薬剤組成物 |
KR100628603B1 (ko) * | 2001-09-03 | 2006-09-26 | 디에스엠 아이피 어셋츠 비.브이. | 펙틴 및 아스코르브산을 포함하는 조성물 |
AU2003220058B2 (en) * | 2002-03-12 | 2008-05-01 | Toyama Chemical Company Limited | Palatable oral suspension and method |
DK1578350T3 (da) * | 2002-03-26 | 2009-08-10 | Euro Celtique Sa | Sammensætninger med gel-coating med depotvirkning |
EP1492511B3 (fr) * | 2002-04-09 | 2012-05-02 | Flamel Technologies | Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s) |
US20030198892A1 (en) * | 2002-04-22 | 2003-10-23 | General Electric Company | Limited play data storage media and method for limiting access to data thereon |
US20030205323A1 (en) * | 2002-04-22 | 2003-11-06 | General Electric Company | Method for making limited play data storage media |
AU2003249904A1 (en) * | 2002-07-02 | 2004-01-23 | Laboratorios S.A.L.V.A.T., S.A. | Stable oily suspension of microgranules |
CA2492789C (en) * | 2002-07-17 | 2012-07-03 | Eurand Pharmaceuticals Limited | Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate |
US20040208936A1 (en) * | 2002-07-22 | 2004-10-21 | Roland Chorin | Novel compositions |
KR20040011087A (ko) * | 2002-07-27 | 2004-02-05 | 주식회사 씨티씨바이오 | 불쾌한 맛과 향을 차폐할 수 있는 록시스로마이신 과립의제조방법 |
US20040087692A1 (en) * | 2002-10-30 | 2004-05-06 | Dixit Arun Nandkishor | Method for preparation of an anthraquinone colorant composition |
US20060159758A1 (en) * | 2002-12-11 | 2006-07-20 | Rajesh Gandhi | Coating composition for taste masking coating and methods for their application and use |
US20040146553A1 (en) * | 2002-12-23 | 2004-07-29 | Aventis Pharma S.A. | Compositions for oral administration of active principles requiring masking of taste |
US20040170686A1 (en) * | 2003-01-31 | 2004-09-02 | Fredrickson Jennifer K. | Suspension vehicle for coated drug particles |
BRPI0407368A (pt) * | 2003-02-10 | 2006-02-14 | Bayer Healthcare Ag | tratamento de doenças bacterianas dos órgãos respiratórios mediante aplicação local e fluor-quinolonas. |
US20040192781A1 (en) * | 2003-03-31 | 2004-09-30 | Haley Eugene T. | Method of administration for metoclopramide and pharmaceutical formulation therefor |
US20050137265A1 (en) * | 2003-03-31 | 2005-06-23 | Haley Eugene T. | Rapidly dissolving metoclopramide solid oral dosage and method thereof |
US7087282B2 (en) * | 2003-07-15 | 2006-08-08 | General Electric Company | Limited play optical storage medium, method for making the same |
US7202292B2 (en) * | 2003-07-15 | 2007-04-10 | General Electric Company | Colored polymeric resin composition with 1,8-diaminoanthraquinone derivative, article made therefrom, and method for making the same |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
JP2005343800A (ja) * | 2004-05-31 | 2005-12-15 | Lion Corp | 被覆カフェイン粒子、固形製剤および眠気防止薬 |
US7854943B2 (en) * | 2004-06-24 | 2010-12-21 | Idexx Laboratories | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
US7858115B2 (en) * | 2004-06-24 | 2010-12-28 | Idexx Laboratories | Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
KR101306088B1 (ko) * | 2005-06-21 | 2013-09-09 | 메르크 파텐트 게엠베하 | (r)-(-)-2-[5-(4-플루오로페닐)-3-피리딜-메틸아미노메틸]크로만을 함유하는 고형 약제학적 조성물 |
US20080213441A1 (en) * | 2006-12-27 | 2008-09-04 | Cathy Jean Ludwig | Reduction of Astringency in Polyphenol Compositions |
BRPI0701693A2 (pt) * | 2007-05-10 | 2008-12-23 | Inst Pesquisas Sao Paulo | processo de encapsulaÇço de substÂncias quÍmicamente ativas e produto encapsulado resultante |
KR100867639B1 (ko) | 2007-06-08 | 2008-11-10 | (주)다산메디켐 | 고미가 차폐된 염산 도네페질-함유 입자, 이를 포함하는약학 조성물, 및 이들의 제조방법 |
US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
DE102008035542A1 (de) | 2008-07-30 | 2010-02-04 | Siemens Aktiengesellschaft | Verfahren zur Ermittlung von Messdaten aus dem Magen eines Patienten |
US8716263B2 (en) | 2008-12-23 | 2014-05-06 | Gilead Pharmasset Llc | Synthesis of purine nucleosides |
US8551973B2 (en) * | 2008-12-23 | 2013-10-08 | Gilead Pharmasset Llc | Nucleoside analogs |
EP3222628A1 (en) * | 2008-12-23 | 2017-09-27 | Gilead Pharmasset LLC | Nucleoside phosphoramidates |
TWI576352B (zh) | 2009-05-20 | 2017-04-01 | 基利法瑪席特有限責任公司 | 核苷磷醯胺 |
US8956654B2 (en) | 2009-06-02 | 2015-02-17 | Dow Global Technologies Llc | Sustained release dosage form |
TWI471146B (zh) * | 2009-12-02 | 2015-02-01 | Aptalis Pharma Ltd | 菲索特芬那定(fexofenadine)微膠囊及包含其之組合物 |
US20110236494A1 (en) * | 2010-03-04 | 2011-09-29 | Ranbaxy Laboratories Limited | Ciprofloxacin oral suspension |
PT3290428T (pt) | 2010-03-31 | 2021-12-27 | Gilead Pharmasset Llc | Comprimido compreendendo 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-dioxo-3,4-dihidropirimidin-1-(2h)-il)¿4¿fluoro¿3¿hidroxi¿4¿metiltetrahidrofuran¿2¿il)metoxi) (fenoxi)fosforil)amino)propanoato de (s)- isopropil cristalino |
PL3290428T3 (pl) | 2010-03-31 | 2022-02-07 | Gilead Pharmasset Llc | Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu |
UY33312A (es) | 2010-03-31 | 2011-10-31 | Pharmasset Inc | Fosforamidato de nucleosido de purina |
AU2010351281B2 (en) * | 2010-04-12 | 2014-03-20 | S. Zhaveri Pharmakem Pvt. Ltd. | Ciprofloxacin dry syrup composition |
CN101985044B (zh) * | 2010-07-16 | 2013-10-23 | 钟术光 | 一种掩味的药物涂层组合物 |
AU2011336632B2 (en) | 2010-11-30 | 2015-09-03 | Gilead Pharmasset Llc | Compounds |
CN102526124B (zh) * | 2011-01-31 | 2013-11-20 | 成都科尔医药技术有限公司 | 一种中药粉体及其制备方法 |
WO2013024036A1 (en) | 2011-08-12 | 2013-02-21 | Boehringer Ingelheim Vetmedica Gmbh | Funny current (if) inhibitors for use in a method of treating and preventing heart failure in feline |
CA2906107C (en) | 2013-03-15 | 2021-08-24 | Aprecia Pharmaceuticals Company | Rapidly dispersible dosage form of oxcarbazepine |
WO2014144661A1 (en) | 2013-03-15 | 2014-09-18 | Aprecia Pharmaceuticals Compny | Rapidly dispersible dosage form of topiramate |
RU2599007C1 (ru) * | 2015-08-24 | 2016-10-10 | Александр Александрович Кролевец | Способ получения нанокапсул ципрофлоксацина гидрохлорида в альгинате натрия |
ITUB20155193A1 (it) * | 2015-11-03 | 2017-05-03 | Italfarmaco Spa | Sospensioni orali di Givinostat fisicamente e chimicamente stabili |
CN105343028B (zh) * | 2015-11-25 | 2018-08-21 | 万邦德制药集团股份有限公司 | 一种诺氟沙星的药物组合物及其制备方法 |
US20220016074A1 (en) | 2018-11-21 | 2022-01-20 | Rosemont Pharmaceuticals Limited | Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability |
CN116459222A (zh) * | 2023-04-20 | 2023-07-21 | 山东中医药大学附属医院 | 一种匹维溴铵组合物、制剂及其用途 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4994260A (en) * | 1982-05-28 | 1991-02-19 | Astra Lakemedel Aktiebolag | Pharmaceutical mixture |
SE8203953D0 (sv) * | 1982-06-24 | 1982-06-24 | Astra Laekemedel Ab | Pharmaceutical mixture |
DE3808277A1 (de) * | 1988-03-12 | 1989-09-21 | Bayer Ag | Verfahren und vorrichtung zur wirbelschichtspruehgranulation |
DE3565475D1 (en) * | 1984-04-07 | 1988-11-17 | Bayer Ag | Process and apparatus for the production of granules |
US4639458A (en) * | 1985-01-22 | 1987-01-27 | Merck & Co., Inc. | Tablet and formulation |
US4971791A (en) * | 1985-08-26 | 1990-11-20 | The Procter & Gamble Company | Taste masking compositions |
US4764375A (en) * | 1985-09-11 | 1988-08-16 | Kv Pharmaceutical Company | Sachet drug delivery system |
EP0230811B1 (fr) * | 1986-01-24 | 1992-06-03 | Valeo Electronique | Bobine d'allumage à circuit fermé |
SE8605515D0 (sv) * | 1986-12-22 | 1986-12-22 | Astra Laekemedel Ab | A liquid dosage form for oral administration of a pharmaceutically active substance |
FI77573C (fi) * | 1987-05-08 | 1989-04-10 | Orion Yhtymae Oy | Ny konsistens. |
NL193682C (nl) * | 1987-05-14 | 2000-07-04 | Glaxo Group Ltd | Beklede cefuroximaxetilsamenstelling. |
IE59934B1 (en) * | 1987-06-19 | 1994-05-04 | Elan Corp Plc | Liquid suspension for oral administration |
GB8723896D0 (en) * | 1987-10-12 | 1987-11-18 | Aps Research Ltd | Controlled-release formulation |
DE3808116A1 (de) * | 1988-03-11 | 1989-09-21 | Bayer Ag | Zick-zack-sichter |
DE3900811A1 (de) * | 1989-01-13 | 1990-07-19 | Kali Chemie Pharma Gmbh | Neue arzneiform |
DE3920082A1 (de) * | 1989-06-20 | 1991-03-07 | Roehm Gmbh | Filmbildendes waessriges ueberzugsmittel fuer feste arzneimittel, verfahren zu seiner herstellung und verwendung |
US5082669A (en) * | 1989-07-20 | 1992-01-21 | Dainippon Pharmaceutical Co., Ltd. | Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked |
ZA923474B (en) * | 1991-05-20 | 1993-01-27 | Marion Merrell Dow Inc | Diltiazem formulation |
DE4200821A1 (de) * | 1992-01-15 | 1993-07-22 | Bayer Ag | Geschmacksmaskierte pharmazeutische mittel |
-
1992
- 1992-01-15 DE DE4200821A patent/DE4200821A1/de not_active Withdrawn
- 1992-12-17 SK SK3720-92A patent/SK280999B6/sk not_active IP Right Cessation
- 1992-12-17 CZ CS923720A patent/CZ283787B6/cs not_active IP Right Cessation
- 1992-12-30 MX MX9207630A patent/MX9207630A/es unknown
- 1992-12-31 TW TW081110514A patent/TW366286B/zh active
-
1993
- 1993-01-05 DK DK93100079T patent/DK0551820T3/da active
- 1993-01-05 ES ES93100079T patent/ES2141117T3/es not_active Expired - Lifetime
- 1993-01-05 DE DE59309858T patent/DE59309858D1/de not_active Expired - Lifetime
- 1993-01-05 EP EP93100079A patent/EP0551820B1/de not_active Expired - Lifetime
- 1993-01-05 AT AT93100079T patent/ATE186212T1/de active
- 1993-01-11 AU AU31138/93A patent/AU670763B2/en not_active Expired
- 1993-01-12 NZ NZ245658A patent/NZ245658A/en not_active IP Right Cessation
- 1993-01-12 IL IL104362A patent/IL104362A/xx not_active IP Right Cessation
- 1993-01-12 CA CA002087146A patent/CA2087146C/en not_active Expired - Lifetime
- 1993-01-14 ZA ZA93234A patent/ZA93234B/xx unknown
- 1993-01-14 HU HU9300085A patent/HU219592B/hu unknown
- 1993-01-14 KR KR1019930000424A patent/KR100288523B1/ko not_active IP Right Cessation
- 1993-01-14 MY MYPI93000210A patent/MY111177A/en unknown
- 1993-01-14 JP JP02076193A patent/JP3734279B2/ja not_active Expired - Lifetime
- 1993-01-15 PL PL93297399A patent/PL175569B1/pl unknown
- 1993-01-15 RU RU93004416/14A patent/RU2110255C1/ru active
- 1993-01-15 CN CN93101096A patent/CN1052399C/zh not_active Expired - Lifetime
-
1994
- 1994-02-04 US US08/191,741 patent/US5695784A/en not_active Expired - Lifetime
-
1995
- 1995-06-28 HU HU95P/P00493P patent/HU211154A9/hu unknown
-
1996
- 1996-05-24 US US08/653,535 patent/US6136347A/en not_active Expired - Lifetime
-
1998
- 1998-06-10 HK HK98105130A patent/HK1005987A1/xx not_active IP Right Cessation
-
2000
- 2000-01-14 GR GR20000400081T patent/GR3032382T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2141117T3 (es) | Agentes farmaceuticos con sabor enmascarado. | |
DE69604653D1 (de) | Taxol derivate, deren herstellung und diese enthaltende pharmazeutischen zusammenstellungen | |
DE69230046D1 (de) | 2-Bromomelatonin zur Behandlung von Schlafstörungen | |
DE3776946D1 (de) | Nasale verabreichung von arzneimitteln. | |
DE19975040I2 (de) | Medikamente enthaltend Salmeterol und Fluticason | |
FR2682040B1 (fr) | Medicaments pour traiter les troubles gastrointestinaux. | |
ITRM910002A0 (it) | Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento. | |
DE59102701D1 (de) | Arzneimittelzubereitung zur systemischen Behandlung von Zier- und Nutzfischen. | |
DE69004532D1 (de) | Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen. | |
ATA99191A (de) | Arzneimittel enthaltend protein c | |
ATE347886T1 (de) | Arzneizubereitungen enthaltend paclitaxel eingeschlossen in nanopartikeln von polymerischen mizellen | |
ATE28566T1 (de) | Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und ein amin. | |
FR2521010B1 (fr) | Medicaments comportant en tant qu'association au moins une immunotoxine et au moins un ionophore carboxylique monovalent | |
DE69123190D1 (de) | Hirudin enthaltende orale Arzneimittel | |
DE59107240D1 (de) | Emulgatorfreie Emulsionspolymere in pharmazeutischen Zubereitungen mit verzögerter Wirkstofffreigabe und ihre Herstellung | |
DE69111530D1 (de) | Pyridincarbonsäure-Amid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen. | |
FR2690159B1 (fr) | Derives d'acide 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur preparation et les medicaments les contenant. | |
RU92004541A (ru) | Лекарственные средства для лечения воспалительных состояний или для аналгезии | |
FR2685870B1 (fr) | Medicament anticancereux. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 551820 Country of ref document: ES |